IOMEPROL
| Brand name | IOMERVU |
|---|---|
| Active ingredient | IOMEPROL |
| Strength | 17.5GM IODINE/50ML (350MG IODINE/ML) |
| Dosage form | SOLUTION |
| Route | INTRA-ARTERIAL |
| Modality | Small molecule |
| FDA approval | November 2024 |
| Marketing status | DISCN |
| Code | Expires |
|---|---|
| NCE | November 2029 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.